Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B  Fierce Biotech

FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos - FirstWord...

FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos  FirstWord Pharma

FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rival - Endpoints News

FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rival  Endpoints News

BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma

BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree  Fierce Pharma

Champions in Care - Bristol Myers Squibb

Champions in Care  Bristol Myers Squibb

Business Moves: BMS Forms Strategic Partnership in India, Launches Dubai Subsidiary - Insurance J...

Business Moves: BMS Forms Strategic Partnership in India, Launches Dubai Subsidiary  Insurance Journal

Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myer...

Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies  PR Newswire

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour  BioSpace

Harbour BioMed and BMS sign multi-specific antibody collab - Pharmaceutical Technology

Harbour BioMed and BMS sign multi-specific antibody collab  Pharmaceutical Technology

Lithium battery BMS system positive and negative connection wires, battery protection board main ...

Lithium battery BMS system positive and negative connection wires, battery protection board main power cord  Global Sources

Harbour BioMed inks license deal with BMS - The Pharma Letter

Harbour BioMed inks license deal with BMS  The Pharma Letter

Brighton wrestling teams exceling on the mat; BMS girls headed to state - The Covington Leader

Brighton wrestling teams exceling on the mat; BMS girls headed to state  The Covington Leader

Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies - Contract Pharma

Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies  Contract Pharma

BMS Jumps Aboard Harbour’s R&D Ship - Citeline News & Insights

BMS Jumps Aboard Harbour’s R&D Ship  Citeline News & Insights

Harbour Biomed closes busy year with $1B+ BMS deal - BioWorld MedTech

Harbour Biomed closes busy year with $1B+ BMS deal  BioWorld MedTech

Building a healthier future together: Strengthening cancer care across Africa through partnership...

Building a healthier future together: Strengthening cancer care across Africa through partnership  Bristol Myers Squibb

Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy? - BioSpace

Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy?  BioSpace

BMS strikes $1.1B multispecific antibody pact with Harbour - FirstWord Pharma

BMS strikes $1.1B multispecific antibody pact with Harbour  FirstWord Pharma

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)  Bristol Myers Squibb

CAR T cell therapy patient resources - Bristol Myers Squibb

CAR T cell therapy patient resources  Bristol Myers Squibb

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study  BioSpace

BMS Lady Marlins dominate Kenedy - Port Aransas South Jetty

BMS Lady Marlins dominate Kenedy  Port Aransas South Jetty

BMS boys teams’ play against Kenedy yields mixed results - Port Aransas South Jetty

BMS boys teams’ play against Kenedy yields mixed results  Port Aransas South Jetty

Fujitsu's AIRSTAGE Cloud BMS with v3.1.4 - ACHR News

Fujitsu's AIRSTAGE Cloud BMS with v3.1.4  ACHR News

Tri-Cities Airport Ice Rink at Bristol Motor Speedway the Perfect Place for Fun During the Holida...

Tri-Cities Airport Ice Rink at Bristol Motor Speedway the Perfect Place for Fun During the Holidays  Speedway Digest

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psych...

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis  BioPharma Dive

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis  Fierce Pharma

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access...

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to  PharmiWeb.com

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 20...

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025  ts2.tech

Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology - TipRanks

Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology  TipRanks

Harbour inks $90m antibody deal with Bristol Myers Squibb - BioXconomy

Harbour inks $90m antibody deal with Bristol Myers Squibb  BioXconomy

Chris Shibutani, MD - Bristol Myers Squibb

Chris Shibutani, MD  Bristol Myers Squibb

BMS Group enters Dubai, strikes India partnership in MENA–South Asia push - Insurance Business

BMS Group enters Dubai, strikes India partnership in MENA–South Asia push  Insurance Business

Transparency & reporting - Bristol Myers Squibb

Transparency & reporting  Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program  Bristol Myers Squibb

Our research in neuroscience - Bristol Myers Squibb

Our research in neuroscience  Bristol Myers Squibb

Merck, Bristol Myers Squibb plan NJ layoffs (updated) - NJBIZ

Merck, Bristol Myers Squibb plan NJ layoffs (updated)  NJBIZ

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” - Clinical Trials Arena

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities”  Clinical Trials Arena

Driving patient-centric care through global patient outreach - Bristol Myers Squibb

Driving patient-centric care through global patient outreach  Bristol Myers Squibb

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients  Bain Capital

Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D  Bristol Myers Squibb

Why Bristol-Myers Squibb (BMY) Stock Is Up Today - Yahoo Finance

Why Bristol-Myers Squibb (BMY) Stock Is Up Today  Yahoo Finance

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it?  Bristol Myers Squibb

Avatar: Fire And Ash Box Office Day 2 India: 17% Jump In BMS Sales Already, On Track To Hit 1 Mil...

Avatar: Fire And Ash Box Office Day 2 India: 17% Jump In BMS Sales Already, On Track To Hit 1 Million BMS Sales In 48 Hours!  Koimoi

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs  Bristol Myers Squibb

APMT, BMS sign Apapa lease through 2031 - Port Technology

APMT, BMS sign Apapa lease through 2031  Port Technology

The evolution of wireless BMS in EVs and high-voltage systems - EVreporter •

The evolution of wireless BMS in EVs and high-voltage systems  EVreporter •

BMS’ Phase III trial of Reblozyl misses primary endpoint - Clinical Trials Arena

BMS’ Phase III trial of Reblozyl misses primary endpoint  Clinical Trials Arena

By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway - Speedway Digest

By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway  Speedway Digest

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing  Fierce Pharma

FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease - Neurology Live

FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease  Neurology Live

From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer - Bristol Myers Squibb

From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer  Bristol Myers Squibb

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent ...

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan  Fortune

Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies - ge...

Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies  geneonline.com

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover  BioSpace

Psoriasis around the world - Bristol Myers Squibb

Psoriasis around the world  Bristol Myers Squibb

BMS Group Announces Further Expansion - - Insurance Edge

BMS Group Announces Further Expansion -  Insurance Edge

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future  Fierce Biotech

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia  Fierce Biotech

BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma

BMS, Bain Capital team up on autoimmune-focused newco  FirstWord Pharma

Bristol Myers Squibb wins fifth US approval for CAR T cell therapy Breyanzi - European Pharmaceut...

Bristol Myers Squibb wins fifth US approval for CAR T cell therapy Breyanzi  European Pharmaceutical Review

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C  Bristol Myers Squibb

Dhurandhar Box Office Day 16 Ticket Sales: Ranveer Singh's Blockbuster Hits 423 Sold Tix Every Si...

Dhurandhar Box Office Day 16 Ticket Sales: Ranveer Singh's Blockbuster Hits 423 Sold Tix Every Single Minute - Roaring BMS Trends!  Koimoi

Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration  Bristol Myers Squibb

Honoring oncologists through the Time Back campaign - Bristol Myers Squibb

Honoring oncologists through the Time Back campaign  Bristol Myers Squibb

Our science - Bristol Myers Squibb

Our science  Bristol Myers Squibb

Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma

Merck & Co., BMS to lay off over 300 staffers in New Jersey  FirstWord Pharma

Bristol Myers Squibb (BMS): Navigating the Patent Cliff with a Renewed Pipeline and Strategic Acq...

Bristol Myers Squibb (BMS): Navigating the Patent Cliff with a Renewed Pipeline and Strategic Acquisitions  FinancialContent

Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva

Bristol Myers Squibb Commits to Veeva Vault CRM  Veeva

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal  Fierce Pharma

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line  BioSpace

BMS Group Forms Partnership With Berns Brett India - - Insurance Edge

BMS Group Forms Partnership With Berns Brett India -  Insurance Edge

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA - Fierce Pharma

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA  Fierce Pharma

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative ...

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection  Bristol Myers Squibb

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer t...

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test  Fierce Biotech

FDA Action Alert: BMS, GSK, Amgen and More - BioSpace

FDA Action Alert: BMS, GSK, Amgen and More  BioSpace

A global journey through BMS’ R&D hubs - Bristol Myers Squibb

A global journey through BMS’ R&D hubs  Bristol Myers Squibb

Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial - statnews.com

Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial  statnews.com

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial  Fierce Biotech

BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology

BMS expands CAR-T portfolio with $1.5bn Orbital buyout  Pharmaceutical Technology

Our impact - Bristol Myers Squibb

Our impact  Bristol Myers Squibb

BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma

BMS to close Illinois site as part of cell therapy manufacturing consolidation  FirstWord Pharma

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future  Fierce Pharma

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC  BioSpace

BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...

BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel  UroToday

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients  Fierce Pharma

Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb

Doctorx Unscripted Bold Conversations about Patient-Driven Science  Bristol Myers Squibb

Water stewardship for environmental sustainability - Bristol Myers Squibb

Water stewardship for environmental sustainability  Bristol Myers Squibb

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise - Yahoo Finance

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise  Yahoo Finance

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS  Kaseya

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence  Fierce Biotech

Looking to the Future of Cell Therapy - Bristol Myers Squibb

Looking to the Future of Cell Therapy  Bristol Myers Squibb

BMS boosts cancer trials with Sarah Cannon's clinical research platform - Fierce Biotech

BMS boosts cancer trials with Sarah Cannon's clinical research platform  Fierce Biotech

BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma

BMS, Pfizer launch direct-to-consumer push for Eliquis in the US  FirstWord Pharma

BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant - BioSpace

BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant  BioSpace

BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma

BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO  FirstWord Pharma

FDA Grants Fast Track Designation to BMS-986446 for Treatment of Early Alzheimer Disease - Pharma...

FDA Grants Fast Track Designation to BMS-986446 for Treatment of Early Alzheimer Disease  Pharmacy Times

Bristol Myers Squibb Spins Out Immunology Assets into New Company Backed by Bain Capital - PharmE...

Bristol Myers Squibb Spins Out Immunology Assets into New Company Backed by Bain Capital  PharmExec.com

I-See-BMs: Chinese Nuclear Policy Under Xi Jinping - Foreign Policy Research Institute

I-See-BMs: Chinese Nuclear Policy Under Xi Jinping  Foreign Policy Research Institute

Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech

Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC  Fierce Biotech